← Leaderboards
Ivan B Yanachkov
Glsynthesis, Inc.
$5,577,894
Attributed
$5,577,894
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2007–15$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,577,894 · 4
By mechanism
R44$4,945,058 · 2
R43$632,836 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorPlayPropertyRattusPlatelet AggregationHemorrhageMyocardial InfarctionPlatelet ActivationPharmaceutical PreparationsPathologyClopidogrelHemostatic FunctionAdp ReceptorsBlood PlateletsCause Of DeathAntiplatelet DrugsIn VivoCanis FamiliarisEventDiadenosine TetraphosphateAnalogOperative Surgical ProceduresAspirinResponse
Grant awards (7)
Novel Antithrombotic Diadenosine Tetraphosphate Analogs$1,417,233
R44 · FY2015 · TR · contact PI
Novel Antithrombotic Diadenosine Tetraphosphate Analogs$858,985
R44 · FY2014 · TR · contact PI
Novel Antithrombotic Diadenosine Tetraphosphate Analogs$1,120,723
R44 · FY2013 · TR · contact PI
Novel Antithrombotic Diadenosine Tetraphosphate Analogs$779,748
R44 · FY2010 · HL · contact PI
Novel Antithrombotic Diadenosine Tetraphosphate Analogs$768,369
R44 · FY2009 · HL · contact PI
Novel Antithrombotic Diadenosine Tetraphosphate Analogs$333,166
R43 · FY2007 · HL · contact PI
Diadenosine Boranotetraphosph(on)ates as Antithrombotic Drugs$299,670
R43 · FY2007 · HL · contact PI